References
- FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
- NguyenDXBosPDMassagueJMetastasis: from dissemination to organ-specific colonizationNat Rev Cancer20099427428419308067
- PantelKAlix-PanabièresCReal-time liquid biopsy in cancer patients: fact or fiction?Cancer Res201373216384638824145355
- YuMBardiaAWittnerBSCirculating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal compositionScience2013339611958058423372014
- GruberILandenbergerNStaeblerAHahnMWallwienerDFehmTRelationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancerAnticancer Res20133352233223823645781
- CleverDRoychoudhuriRConstantinidesMGOxygen sensing by T cells establishes an immunologically tolerant metastatic nicheCell201616651117113127565342
- MegoMGaoHCohenENCirculating tumor cells (CTC) are associated with defects in adaptive immunity in patients with inflammatory breast cancerJ Cancer2016791095110427326253
- MittalDGubinMMSchreiberRDSmythMJNew insights into cancer immunoediting and its three component phases-elimination, equilibrium and escapeCurr Opin Immunol201427625
- WangJWangKXuJHuangJZhangTPrognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysisPLoS One2013811e7807024223761
- WanJWGaoMZHuRJA preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancerAnn Transl Med201532235226807407
- PunnooseEAAtwalSLiuWEvaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinibClin Cancer Res20121882391240122492982
- ThalgottMRackBEiberMCategorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patientsBMC Cancer20151545826051431
- GoldstrawPChanskyKCrowleyJThe IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancerJ Thorac Oncol2016111395126762738
- TsongalisGJBranched DNA technology in molecular diagnosticsAm J Clin Pathol2006126344845316880139
- WuSLiuSLiuZClassification of circulating tumor cells by epithelial-mesenchymal transition markersPLoS One2015104e012397625909322
- Bednarz-KnollNAlix-PanabièresCPantelKPlasticity of disseminating cancer cells in patients with epithelial malignanciesCancer Metastasis Rev2012313–467368722733306
- HanssenAWagnerJGorgesTMCharacterization of different CTC subpopulations in non-small cell lung cancerSci Rep201662801027302574
- BarriereGRiouallonARenaudieJTartaryMRigaudMMesenchymal characterization: alternative to simple CTC detection in two clinical trialsAnticancer Res20123283363336922843916
- TamWLWeinbergRAThe epigenetics of epithelial-mesenchymal plasticity in cancerNat Med201319111438144924202396
- JoosseSAGorgesTMPantelKBiology, detection, and clinical implications of circulating tumor cellsEMBO Mol Med201471111
- GodinhoSAPiconeRBuruteMOncogene-like induction of cellular invasion from centrosome amplificationNature2014510750316717124739973
- AcetoNBardiaAMiyamotoDTCirculating tumor cell clusters are oligoclonal precursors of breast cancer metastasisCell201415851110112225171411
- FörnvikDAnderssonIDustlerMNo evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compressionBreast Cancer Res Treat2013141218719523990353
- Celià-TerrassaTMeca-CortésOMateoFEpithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cellsJ Clin Invest201212251849186822505459
- PantelKBrakenhoffRHDissecting the metastatic cascadeNat Rev Cancer20044644845615170447
- RiethdorfSWikmanHPantelKReview: biological relevance of disseminated tumor cells in cancer patientsInt J Cancer200812391991200618712708
- KangYPantelKTumor cell dissemination: emerging biological insights from animal models and cancer patientsCancer Cell201323557358123680145
- PantelKAlix-PanabièresCBone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patientsBonekey Rep2014358425419458
- BidardFCPeetersDJFehmTClinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient dataLancet Oncol201415440641424636208
- KrebsMGRenehanAGBackenACirculating tumor cell enumeration in a phase II trial of a four-drug regimen in advanced colorectal cancerClin Colorectal Cancer201514211512225680623
- KitamuraTQianBZPollardJWImmune cell promotion of metastasisNat Rev Immunol2015152738625614318
- PancioneMGiordanoGRemoAImmune escape mechanisms in colorectal cancer pathogenesis and liver metastasisJ Immunol Res2014201468687924741617
- LarbiAZelbaHGoldeckDPawelecGInduction of HIF-1alpha and the glycolytic pathway alters apoptotic and differentiation profiles of activated human T cellsJ Leukoc Biol201087226527319892848
- WangRGreenDRMetabolic checkpoints in activated T cellsNat Immunol2012131090791522990888
- ChangCHQiuJO’SullivanDMetabolic competition in the tumor microenvironment is a driver of cancer progressionCell201516261229124126321679
- TosoliniMKirilovskyAMlecnikBClinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancerCancer Res20117141263127121303976